Delivery Order SPE2DB20D7059-SPE2DB25FPTA2
Award Date
10/22/24
Potential Completion Date
10/23/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical product to the Defense Logistics Agency (DLA). The $8,793.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, to the U.S. government. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,068.41 and is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of September 18, 2024. This award is not associated with any set-aside program....
The federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide Fluticasone Prop HFA 110 MCG 12GM medication. The $1,909.40 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of August 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to...
This federal contract award, valued at $1,031.10, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a period of performance through March 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract has a ceiling value of $1,607.26 and is a delivery order under an...
This federal contract award is for the delivery of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product, to the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,643.14, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 18, 2024, with a completion date of July 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation....
This federal contract award is for the delivery of 4565877563 units of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $4,874.35, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of September 20, 2024. This award is part of a larger Indefinite Delivery...
This federal contract award is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical, a major agency within the U.S. Department of Defense that procures medical supplies and equipment. The $1,225.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $8,072.66 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal agencies. The contract has an ultimate completion date of December 19, 2024 and does not have a...
This federal contract award is for the delivery of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,255.54, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a Firm Fixed Price basis. This appears to be a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves...